Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    16522809 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant
Condition: Hematologic Neoplasms
Intervention: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Study has passed its completion date and status has not been verified in more than two years.